Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
PRS Kliniek is a specialized medical center located in Bilthoven, Netherlands, focused on regenerative medicine and autologous cell therapies. The clinic utilizes a proprietary technology known as Platelet Rich Stroma (PRS), which is marketed as a more advanced and potent alternative to standard Platelet Rich Plasma (PRP) treatments. PRS therapy involves extracting a specific fraction of the patient's own blood that contains a high concentration of regenerative cells, white blood cells, and growth factors to stimulate tissue repair. The clinic primarily provides commercial treatments for hair loss, skin rejuvenation, and orthopedic conditions such as joint pain and osteoarthritis. By leveraging the body's natural healing mechanisms, PRS Kliniek offers minimally invasive options for patients seeking alternatives to traditional surgery or synthetic fillers.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on PRSkliniek.